Vivos Therapeutics (VVOS) Profit After Tax Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 12.92% |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn | -10.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.74% |
| Dec 31, 2025 | -144.15% |
| Sep 30, 2025 | -107.69% |
| Jun 30, 2025 | -159.74% |
| Mar 31, 2025 | -3.64% |
| Dec 31, 2024 | 34.05% |
| Sep 30, 2024 | -24.22% |
| Jun 30, 2024 | 65.09% |
| Mar 31, 2024 | -120.96% |
| Dec 31, 2023 | 28.33% |
| Sep 30, 2023 | 61.48% |
| Jun 30, 2023 | 20.94% |
| Mar 31, 2023 | 68.05% |
| Dec 31, 2022 | 18.79% |
| Sep 30, 2022 | 0.35% |
| Jun 30, 2022 | -72.94% |
| Mar 31, 2022 | -56.84% |
| Dec 31, 2021 | -17.41% |
| Sep 30, 2021 | -200.74% |
| Jun 30, 2021 | -185.99% |